Here’s what investors need to know. Shares of prominent psychedelics companies, including Compass Pathways, Atai Life Sciences, and Mind Medicine, experienced a significant decline following
Donanemab is a monoclonal antibody designed to ablate amyloid plaques that aggregate in patients with Alzheimer’s disease. Credit: Tada Images/Shutterstock.com Despite being delayed twice, the
When temperatures soar, so do heart attacks. Now, a lab experiment explains just how temperatures climbing into Fahrenheit’s three-digits can cause ischemia and potential heart
Advisers to the Food and Drug Administration voted 11-0 on Monday to recommend the approval of a drug for early Alzheimer’s disease made by Eli
An illustration of a diseased liver. The drug survodutide has significantly improved the resolution of liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH). Image
What You Should Know: – Asensus Surgical, Inc. (NYSE American: ASXC), a leading developer of digital surgical technologies, announced today it has entered into a
Dive Brief: Abbott said Monday it will launch two over-the-counter continuous glucose monitors after receiving clearance from the Food and Drug Administration. One product is
Dive Brief: Johnson & Johnson received 510(k) clearance for its Velys surgical robot for use in partial knee replacement procedures, the company said Thursday J&J
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Boston Scientific “appears likely to
Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular